Company profile: Lexitas
1.1 - Company Overview
Company description
- Provider of full-service ophthalmology CRO solutions for pharma and biotech, including end-to-end clinical operations, global site relationships and international regulatory expertise, medical and regulatory writing, medical monitoring, reading center image assessments, and data management, biostatistics, and statistical programming.
Products and services
- Clinical Operations: Full-range service that architects ophthalmic studies from design to close-out, planning, implementing, managing, and executing the entire process with continuous operational planning and execution
- Data Management, Biostatistics & Statistical Programming: Ophthalmology-focused analytics that turns trial data into actionable insights with expertise in data management, biostatistics, and statistical programming
- Reading Center Services: Imaging-centric assessments delivering accurate, efficient, and timely image assessments with direct communication and transparency
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lexitas
Genflow Biosciences
HQ: United States
Website
- Description: Provider of synthetic biology-based gene therapies to delay or stop aging in humans and dogs, focused on the development and promotion of creative treatments that target aging to extend life expectancy in both humans and canines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genflow Biosciences company profile →
Q1 Scientific
HQ: Ireland
Website
- Description: Provider of environmentally controlled stability storage services for the pharmaceutical, medical device and life sciences industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q1 Scientific company profile →
Lisapharma
HQ: Italy
Website
- Description: Provider of sterile injectable medicines and contract manufacturing for sterile and non-sterile products (liquids, semi-solids, medical devices). Offers pharmacovigilance; R&D (analytical method development, forced degradation, product characterization, stability); and quality control (chemical-physical, microbiological, packaging analysis). Acurmil (Atracurium Besilate) IV injectable muscle relaxant. Based in Erba, Italy; active in 40+ countries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lisapharma company profile →
Evotec
HQ: Germany
Website
- Description: Provider of drug discovery and gene therapy solutions, delivering CRO/CDMO services from initial research to clinical trials; AI-powered PanOmics and iPSC technologies for disease understanding in small molecules and biotherapeutics; hit identification; J.POD continuous biomanufacturing for biologics; and a proprietary ion channel assay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evotec company profile →
Lyophilization Services
HQ: United States
Website
- Description: Provider of lyophilization services to the pharmaceutical, biotechnology, and medical device industries, producing products in a timely, reliably consistent, GMP-compliant manner with a focus on quality and patient safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lyophilization Services company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lexitas
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lexitas
2.2 - Growth funds investing in similar companies to Lexitas
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lexitas
4.2 - Public trading comparable groups for Lexitas
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →